Name: Lacticaseibacillus rhamnosus CCUG 34291
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 147820

Type strain:

Species: Lacticaseibacillus rhamnosus

Culture col. no.: CCUG 34291, ATCC 53103, LMG 18243

NCBI tax ID(s): 47715 (species)

SI-ID 8915

LMG 17291, CCM 7091, ATCC 53103, LMG 18243, CCUG 34291, BCRC 16000, CCRC 16000, KCTC 5033, VTT E-96666

Other strains from Lacticaseibacillus rhamnosus

L. rhamnosus DSM 20021, ATCC 7469, CCM 1825, ... (type strain)
L. rhamnosus A17/70, DSM 8743, NCFB 2978
L. rhamnosus A102/70, DSM 8744, NCFB 2979
L. rhamnosus 100171, DSM 8745, NCFB 2980
L. rhamnosus GK1, DSM 8746, NCFB 2981
L. rhamnosus CCUG 38017, JCM 1165, DSM 20022, ...
L. rhamnosus L 541, DSM 20023, ATCC 14957
L. rhamnosus 4R2127, DSM 20245, ATCC 11979, ...
L. rhamnosus 280-16, DSM 20247, ATCC 12116
L. rhamnosus DSM 20711, ATCC 10863, NCIB 9282, ...
L. rhamnosus PA11, DSM 111733
L. rhamnosus JCM 1553, ATCC 11443, BCRC 12321
L. rhamnosus JCM 1563, ATCC 27773
L. rhamnosus JCM 20100, IAM 1197
L. rhamnosus JCM 2771
L. rhamnosus JCM 2772
L. rhamnosus JCM 31651
L. rhamnosus JCM 8134, ATCC 11981, CCM 1836, ...
L. rhamnosus JCM 8136, NCFB 1051
L. rhamnosus JCM 8602
L. rhamnosus JCM 8649

Section

Lacticaseibacillus rhamnosus CCUG 34291 is an aerobe, mesophilic bacterium that was isolated from Human feces.

aerobe
mesophilic
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Lactobacillales*
	Family	*Lactobacillaceae*
	Genus	*Lacticaseibacillus*
	Species	**Lacticaseibacillus rhamnosus**
	Full Scientific Name (LPSN)	Lacticaseibacillus rhamnosus (Hansen 1968) Zheng et al. 2020

	Synonym	Lactobacillus casei subsp. rhamnosus
	Synonym	Lactobacillus rhamnosus

Information on morphological and physiological properties Morphology

[Ref.: #69480]	Gram stain	positive Confidence in %100

[Ref.: #69480]	Motility	no Confidence in %97.167

Information on culture and growth conditions Culture and growth conditions

	Temperatures	Kind of temperature		Temperature
[Ref.: #52036]			growth	37 °C

[Ref.: #52036]

Temperature range

mesophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #52036]

Oxygen tolerance

aerobe

[Ref.: #69480]	Ability of spore formation	no Confidence in %99.945
[Ref.: #69481]	Ability of spore formation	no Confidence in %100

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68381]	alpha-cyclodextrin ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68371]	amygdalin ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	arbutin ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68381]	arginine ChEBI	-	hydrolysis	* from API rID32STR
[Ref.: #68371]	cellobiose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-arabinose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-arabitol ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	D-fructose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-fucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-galactose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-glucose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-lyxose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-mannitol ChEBI	+	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	D-mannose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-ribose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68381]	D-ribose ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68371]	D-sorbitol ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-tagatose ChEBI	+	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	D-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	erythritol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	esculin ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	galactitol ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	gentiobiose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	gluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycerol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycogen ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68381]	hippurate ChEBI	+	hydrolysis	* from API rID32STR
[Ref.: #68371]	inulin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-arabinose ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	L-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-fucose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-rhamnose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-sorbose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	lactose ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	maltose ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	melezitose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68381]	melezitose ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68371]	melibiose ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	methyl alpha-D-glucopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-mannoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68381]	methyl beta-D-glucopyranoside ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68371]	methyl beta-D-xylopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	myo-inositol ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	N-acetylglucosamine ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	Potassium 2-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	Potassium 5-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68381]	pullulan ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68371]	raffinose ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	ribitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	salicin ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68381]	sorbitol ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68371]	starch ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	sucrose ChEBI	-	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	trehalose ChEBI	+	builds acid from	* from API 50CH acid, API rID32STR
[Ref.: #68371]	turanose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68381]	urea ChEBI	-	hydrolysis	* from API rID32STR
[Ref.: #68371]	xylitol ChEBI	-	builds acid from	* from API 50CH acid
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite	Production
[Ref.: #68381]		acetoin ChEBI	yes	* from API rID32STR

	Physiological tests	Metabolite	Voges-Proskauer-test
[Ref.: #68381]		acetoin ChEBI	+	* from API rID32STR

	Enzyme	Enzyme activity	EC number
[Ref.: #68381]	Alanyl-Phenylalanyl-Proline arylamidase	+		* from API rID32STR
[Ref.: #68381]	alkaline phosphatase	-	3.1.3.1	* from API rID32STR
[Ref.: #68381]	alpha-galactosidase	-	3.2.1.22	* from API rID32STR
[Ref.: #68381]	arginine dihydrolase	-	3.5.3.6	* from API rID32STR
[Ref.: #68381]	beta-galactosidase	+	3.2.1.23	* from API rID32STR
[Ref.: #68381]	beta-glucosidase	+	3.2.1.21	* from API rID32STR
[Ref.: #68381]	beta-glucuronidase	-	3.2.1.31	* from API rID32STR
[Ref.: #68381]	beta-mannosidase	-	3.2.1.25	* from API rID32STR
[Ref.: #68381]	glycyl tryptophan arylamidase	-		* from API rID32STR
[Ref.: #68381]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API rID32STR
[Ref.: #68381]	pyrrolidonyl arylamidase	+	3.4.19.3	* from API rID32STR
[Ref.: #68381]	urease	-	3.5.1.5	* from API rID32STR
	Only first 10 entries are displayed. Click here to see all.

API® 50CH acid:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	Acid from glycerolGLY	Acid from erythritolERY	Acid from D-arabinoseDARA	Acid from L-arabinoseLARA	Acid from D-riboseRIB	Acid from D-xyloseDXYL	Acid from L-xyloseLXYL	Acid from D-adonitolADO	Acid from methyl beta-D-xylopyranosideMDX	Acid from D-galactoseGAL	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from L-sorboseSBE	Acid from L-rhamnoseRHA	Acid from dulcitolDUL	Acid from inositolINO	Acid from D-mannitolMAN	Acid from D-sorbitolSOR	Acid from methyl alpha-D-mannopyranosideMDM	Acid from methyl alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Acid from amygdalinAMY	Acid from arbutinARB	Acid from esculinESC	Acid from salicinSAL	Acid from cellobioseCEL	Acid from maltoseMAL	Acid from lactoseLAC	Acid from melibioseMEL	Acid from sucroseSAC	Acid from trehaloseTRE	Acid from inulinINU	Acid from melezitoseMLZ	Acid from raffinoseRAF	Acid from starchAMD	Acid from glycogenGLYG	Acid from xylitolXLT	Acid from gentiobioseGEN	Acid from turanoseTUR	Acid from D-lyxoseLYX	Acid from D-tagatoseTAG	Acid from D-fucoseDFUC	Acid from L-fucoseLFUC	Acid from D-arabitolDARL	Acid from L-arabitolLARL	Acid from gluconateGNT	Acid from 2-Ketogluconate2KG	Acid from 5-Ketogluconate5KG
[Ref.: #52036]	3542	-	-	-	+	-	+	-	-	-	-	+	+	+	+	-	+	+	+	+	+	-	-	+	+	+	+	+	+	-	-	-	-	+	-	+	-	-	-	-	+	-	-	+	-	+	-	-	-	-	-

API® rID32STR:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Arginine dihydrolaseADH (Arg)	beta-Glucosidasebeta GLU	beta-Galactosidasebeta GAR	beta-Glucuronidasebeta GUR	alpha-Galactosidasealpha GAL	Alkaline PhosphatasePAL	Acid from D-riboseRIB	Acid from D-mannitolMAN	Acid from sorbitolSOR	Acid from lactoseLAC	Acid from trehaloseTRE	Acid from raffinoseRAF	Acid from sucroseSAC	Acid from L-arabinoseLARA	Acid from D-arabitolDARL	Acid from alpha-cyclodextrinCDEX	Acetoin production (Voges Proskauer test)VP	Alanyl-Phenylalanyl-Proline arylamidaseAPPA	beta-Galactosidasebeta GAL	Pyrrolidonyl arylamidasePyrA	N-Acetyl-glucosaminidasebeta NAG	Glycyl-tryptophan arylamidaseGTA	Hydrolysis of hippuric acidHIP	Acid from glycogenGLYG	Acid from pullulanPUL	Acid from maltoseMAL	Acid from melibioseMEL	Acid from melezitoseMLZ	Acidification of methyl beta-D-glucopyranosideMbeta DG	Acid from D-tagatoseTAG	beta-Mannosidasebeta MAN	Urease/urea hydrolysisURE
[Ref.: #52036]	3760	-	+	+	-	-	-	-	+	-	-	+	-	-	-	-	-	+	+	+	+	-	-	+	-	-	-	-	-	-	+	-	-

	Pathway	Enzyme coverage	Annotated reactions
	Pathway annotation	Computationally determined by
[Ref.: #66794]	gluconeogenesis	100	8 of 8
[Ref.: #66794]	C4 and CAM-carbon fixation	100	8 of 8
[Ref.: #66794]	acetate fermentation	100	4 of 4
[Ref.: #66794]	ribulose monophosphate pathway	100	2 of 2
[Ref.: #66794]	ppGpp biosynthesis	100	4 of 4
[Ref.: #66794]	coenzyme A metabolism	100	4 of 4
[Ref.: #66794]	CDP-diacylglycerol biosynthesis	100	2 of 2
[Ref.: #66794]	UDP-GlcNAc biosynthesis	100	3 of 3
[Ref.: #66794]	cis-vaccenate biosynthesis	100	2 of 2
[Ref.: #66794]	ceramide biosynthesis	100	1 of 1
[Ref.: #66794]	folate polyglutamylation	100	1 of 1
[Ref.: #66794]	anapleurotic synthesis of oxalacetate	100	1 of 1
[Ref.: #66794]	methylglyoxal degradation	100	5 of 5
[Ref.: #66794]	acetoin degradation	100	3 of 3
[Ref.: #66794]	palmitate biosynthesis	90.91	20 of 22
[Ref.: #66794]	pentose phosphate pathway	90.91	10 of 11
[Ref.: #66794]	aspartate and asparagine metabolism	88.89	8 of 9
[Ref.: #66794]	peptidoglycan biosynthesis	86.67	13 of 15
[Ref.: #66794]	vitamin B1 metabolism	84.62	11 of 13
[Ref.: #66794]	degradation of sugar alcohols	81.25	13 of 16
[Ref.: #66794]	starch degradation	80	8 of 10
[Ref.: #66794]	glycogen metabolism	80	4 of 5
[Ref.: #66794]	threonine metabolism	80	8 of 10
[Ref.: #66794]	pyrimidine metabolism	75.56	34 of 45
[Ref.: #66794]	purine metabolism	75.53	71 of 94
[Ref.: #66794]	glycogen biosynthesis	75	3 of 4
[Ref.: #66794]	NAD metabolism	72.22	13 of 18
[Ref.: #66794]	propanol degradation	71.43	5 of 7
[Ref.: #66794]	cardiolipin biosynthesis	71.43	5 of 7
[Ref.: #66794]	photosynthesis	71.43	10 of 14
[Ref.: #66794]	glycolysis	70.59	12 of 17
[Ref.: #66794]	myo-inositol biosynthesis	70	7 of 10
[Ref.: #66794]	phenylalanine metabolism	69.23	9 of 13
[Ref.: #66794]	methionine metabolism	69.23	18 of 26
[Ref.: #66794]	glutamate and glutamine metabolism	67.86	19 of 28
[Ref.: #66794]	cyanate degradation	66.67	2 of 3
[Ref.: #66794]	formaldehyde oxidation	66.67	2 of 3
[Ref.: #66794]	valine metabolism	66.67	6 of 9
[Ref.: #66794]	degradation of hexoses	66.67	12 of 18
[Ref.: #66794]	L-lactaldehyde degradation	66.67	2 of 3
[Ref.: #66794]	d-xylose degradation	63.64	7 of 11
[Ref.: #66794]	ketogluconate metabolism	62.5	5 of 8
[Ref.: #66794]	dTDPLrhamnose biosynthesis	62.5	5 of 8
[Ref.: #66794]	glycine betaine biosynthesis	60	3 of 5
[Ref.: #66794]	3-chlorocatechol degradation	60	3 of 5
[Ref.: #66794]	lipoate biosynthesis	60	3 of 5
[Ref.: #66794]	factor 420 biosynthesis	60	3 of 5
[Ref.: #66794]	Entner Doudoroff pathway	60	6 of 10
[Ref.: #66794]	oxidative phosphorylation	59.34	54 of 91
[Ref.: #66794]	non-pathway related	57.89	22 of 38
[Ref.: #66794]	degradation of pentoses	57.14	16 of 28
[Ref.: #66794]	ubiquinone biosynthesis	57.14	4 of 7
[Ref.: #66794]	CO2 fixation in Crenarchaeota	55.56	5 of 9
[Ref.: #66794]	serine metabolism	55.56	5 of 9
[Ref.: #66794]	d-mannose degradation	55.56	5 of 9
[Ref.: #66794]	metabolism of disaccharids	54.55	6 of 11
[Ref.: #66794]	proline metabolism	54.55	6 of 11
[Ref.: #66794]	degradation of sugar acids	52	13 of 25
[Ref.: #66794]	alanine metabolism	51.72	15 of 29
[Ref.: #66794]	histidine metabolism	51.72	15 of 29
[Ref.: #66794]	cyclohexanol degradation	50	2 of 4
[Ref.: #66794]	sulfopterin metabolism	50	2 of 4
[Ref.: #66794]	6-hydroxymethyl-dihydropterin diphosphate biosynthesis	50	4 of 8
[Ref.: #66794]	tryptophan metabolism	50	19 of 38
[Ref.: #66794]	selenocysteine biosynthesis	50	3 of 6
[Ref.: #66794]	butanoate fermentation	50	2 of 4
[Ref.: #66794]	adipate degradation	50	1 of 2
[Ref.: #66794]	isoleucine metabolism	50	4 of 8
[Ref.: #66794]	ethanol fermentation	50	1 of 2
[Ref.: #66794]	tetrahydrofolate metabolism	50	7 of 14
[Ref.: #66794]	suberin monomers biosynthesis	50	1 of 2
[Ref.: #66794]	glutathione metabolism	50	7 of 14
[Ref.: #66794]	cysteine metabolism	50	9 of 18
[Ref.: #66794]	reductive acetyl coenzyme A pathway	42.86	3 of 7
[Ref.: #66794]	mevalonate metabolism	42.86	3 of 7
[Ref.: #66794]	isoprenoid biosynthesis	42.31	11 of 26
[Ref.: #66794]	degradation of aromatic, nitrogen containing compounds	41.67	5 of 12
[Ref.: #66794]	ascorbate metabolism	40.91	9 of 22
[Ref.: #66794]	lysine metabolism	40.48	17 of 42
[Ref.: #66794]	ethylmalonyl-CoA pathway	40	2 of 5
[Ref.: #66794]	metabolism of amino sugars and derivatives	40	2 of 5
[Ref.: #66794]	glycine metabolism	40	4 of 10
[Ref.: #66794]	cellulose degradation	40	2 of 5
[Ref.: #66794]	arachidonate biosynthesis	40	2 of 5
[Ref.: #66794]	flavin biosynthesis	40	6 of 15
[Ref.: #66794]	vitamin K metabolism	40	2 of 5
[Ref.: #66794]	lipid metabolism	38.71	12 of 31
[Ref.: #66794]	citric acid cycle	35.71	5 of 14
[Ref.: #66794]	glycolate and glyoxylate degradation	33.33	2 of 6
[Ref.: #66794]	chorismate metabolism	33.33	3 of 9
[Ref.: #66794]	acetyl CoA biosynthesis	33.33	1 of 3
[Ref.: #66794]	enterobactin biosynthesis	33.33	1 of 3
[Ref.: #66794]	IAA biosynthesis	33.33	1 of 3
[Ref.: #66794]	lipid A biosynthesis	33.33	3 of 9
[Ref.: #66794]	sphingosine metabolism	33.33	2 of 6
[Ref.: #66794]	octane oxidation	33.33	1 of 3
[Ref.: #66794]	leucine metabolism	30.77	4 of 13
[Ref.: #66794]	urea cycle	30.77	4 of 13
[Ref.: #66794]	phenylpropanoid biosynthesis	30.77	4 of 13
[Ref.: #66794]	propionate fermentation	30	3 of 10
[Ref.: #66794]	arginine metabolism	29.17	7 of 24
[Ref.: #66794]	vitamin B6 metabolism	27.27	3 of 11
[Ref.: #66794]	polyamine pathway	26.09	6 of 23
[Ref.: #66794]	lactate fermentation	25	1 of 4
[Ref.: #66794]	carnitine metabolism	25	2 of 8
[Ref.: #66794]	toluene degradation	25	1 of 4
[Ref.: #66794]	phenol degradation	25	5 of 20
[Ref.: #66794]	CMP-KDO biosynthesis	25	1 of 4
[Ref.: #66794]	vitamin B12 metabolism	23.53	8 of 34
[Ref.: #66794]	sulfate reduction	23.08	3 of 13
[Ref.: #66794]	nitrate assimilation	22.22	2 of 9
[Ref.: #66794]	4-hydroxymandelate degradation	22.22	2 of 9
[Ref.: #66794]	tyrosine metabolism	21.43	3 of 14
		Only first 10 entries are displayed. Click here to see all.

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #52036]	Sample type/isolated from	Human feces
* marker position based on {}

Isolation sources categories

#Host	#Human	-
#Host Body Product	#Gastrointestinal tract	#Feces (Stool)

What are isolation sources categories?

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Lacticaseibacillus rhamnosus GG GG (ATCC 53103)	GCA_000026505	complete	GenBank	568703 tax ID	*
[Ref.: #66792]	Lacticaseibacillus rhamnosus GG ATCC 53103	GCA_000011045	complete	GenBank	568703 tax ID	*
[Ref.: #66792]	Lactobacillus rhamnosus GG ATCC 53103	568703.30	complete	PATRIC	568703 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Lacticaseibacillus rhamnosus GG ATCC 53103 NCBI: GCA_000011045.1
[Ref.: #69481]	spore-forming	no	100	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Lacticaseibacillus rhamnosus GG GG (ATCC 53103) NCBI: GCA_000026505.1
[Ref.: #69480]	motile	no	93.874	no
[Ref.: #69480]	flagellated	no	97.66	no
[Ref.: #69480]	gram-positive	yes	93.955	no
[Ref.: #69480]	anaerobic	no	94.765	no
[Ref.: #69480]	aerobic	no	94.303	yes
[Ref.: #69480]	halophile	yes	80.377	no
[Ref.: #69480]	spore-forming	no	90.694	no
[Ref.: #69480]	glucose-util	yes	92.014	no
[Ref.: #69480]	thermophile	no	97.61	yes
[Ref.: #69480]	glucose-ferment	yes	89.102	no

Availability in culture collections External links

[Ref.: #52036]

Culture collection no.

CCUG 34291, ATCC 53103, LMG 18243

[Ref.: #102489]

SI-ID 8915

Literature:

Only first 10 entries are displayed. Click here to see all.

Topic	Title	Authors	Journal	DOI	Year
Stress	Ribosome Profiling Reveals Genome-Wide Cellular Translational Regulation in Lacticaseibacillus rhamnosus ATCC 53103 under Acid Stress.	Fan X, Zhang K, Zhang Z, Zhang Z, Lin X, Liu X, Feng Z, Yi H	Foods	10.3390/foods11101411	2022	*
Pathogenicity	Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications.	Rossi F, Amadoro C, Gasperi M, Colavita G	Nutrients	10.3390/nu14061178	2022	*
Pathogenicity	Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.	Loke P, Orsini F, Lozinsky AC, Gold M, O'Sullivan MD, Quinn P, Lloyd M, Ashley SE, Pitkin S, Axelrad C, Metcalfe JR, Su EL, Tey D, Robinson MN, Allen KJ, Prescott SL, Galvin AD, Tang MLK	Lancet Child Adolesc Health	10.1016/S2352-4642(22)00006-2	2022	*
Stress	Ribosome Profiling and RNA Sequencing Reveal Genome-Wide Cellular Translation and Transcription Regulation Under Osmotic Stress in Lactobacillus rhamnosus ATCC 53103.	Fan X, Bao T, Yi H, Zhang Z, Zhang K, Liu X, Lin X, Zhang Z, Feng Z	Front Microbiol	10.3389/fmicb.2021.781454	2021	*
Pathogenicity	Influence of fruit-based beverages on efficacy of Lacticaseibacillus rhamnosus GG (Lactobacillus rhamnosus GG) against DSS-induced intestinal inflammation.	Sireswar S, Dey G, Biswas S	Food Res Int	10.1016/j.foodres.2021.110661	2021	*
Enzymology	Enumeration of Probiotic Strain Lacticaseibacillus rhamnosus GG (ATCC 53103) Using Viability Real-time PCR.	Shehata HR, Newmaster SG	Probiotics Antimicrob Proteins	10.1007/s12602-021-09849-6	2021	*
Metabolism	Probiotics Lactobacillus rhamnosus GG ATCC53103 and Lactobacillus plantarum JL01 induce cytokine alterations by the production of TCDA, DHA, and succinic and palmitic acids, and enhance immunity of weaned piglets.	Geng T, He F, Su S, Sun K, Zhao L, Zhao Y, Bao N, Pan L, Sun H	Res Vet Sci	10.1016/j.rvsc.2021.04.011	2021	*
Metabolism	Specific Lactobacillus probiotic strains decrease transepithelial glucose transport through GLUT2 downregulation in intestinal epithelial cell models.	Primec M, Skorjanc D, Langerholc T, Micetic-Turk D, Gorenjak M	Nutr Res	10.1016/j.nutres.2020.11.008	2020	*
Pathogenicity	Study of anti-virus actions of metabolites of lactobacteria.	Kalinichenko SV, Melentyevsmall a, Cyrillic KV, Manee H, Dubinina NV, Zvereva NV, Toryanik II, Popova NG, Pakhomov OV	Wiad Lek		2020	*
Pathogenicity	Lactobacillus rhamnosus GG (ATCC 53103) for the Management of Infantile Colic: A Randomized Controlled Trial.	Savino F, Montanari P, Galliano I, Dapra V, Bergallo M	Nutrients	10.3390/nu12061693	2020	*
Pathogenicity	Anti-Inflammatory and Gut Microbiota Modulatory Effect of Lactobacillus rhamnosus Strain LDTM 7511 in a Dextran Sulfate Sodium-Induced Colitis Murine Model.	Yeo S, Park H, Seo E, Kim J, Kim BK, Choi IS, Huh CS	Microorganisms	10.3390/microorganisms8060845	2020	*
Pathogenicity	Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics.	van den Akker CHP, van Goudoever JB, Shamir R, Domellof M, Embleton ND, Hojsak I, Lapillonne A, Mihatsch WA, Berni Canani R, Bronsky J, Campoy C, Fewtrell MS, Fidler Mis N, Guarino A, Hulst JM, Indrio F, Kolacek S, Orel R, Vandenplas Y, Weizman Z, Szajewska H	J Pediatr Gastroenterol Nutr	10.1097/MPG.0000000000002655	2020	*
Pathogenicity	Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: Pathogenesis and a review for clinicians.	Chiang MC, Chen CL, Feng Y, Chen CC, Lien R, Chiu CH	J Microbiol Immunol Infect	10.1016/j.jmii.2020.03.029	2020	*
Metabolism	Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.	Naudin CR, Maner-Smith K, Owens JA, Wynn GM, Robinson BS, Matthews JD, Reedy AR, Luo L, Wolfarth AA, Darby TM, Ortlund EA, Jones RM	Gastroenterology	10.1053/j.gastro.2020.03.010	2020	*
Pathogenicity	Adhesion and anti-inflammatory potential of Lactobacillus rhamnosus GG in a sea buckthorn based beverage matrix.	Sireswar S, Biswas S, Dey G	Food Funct	10.1039/c9fo02249j	2020	*
Pathogenicity	Effects of regular and decaffeinated roasted coffee (Coffea arabica and Coffea canephora) extracts and bioactive compounds on in vitro probiotic bacterial growth.	Sales AL, dePaula J, Mellinger Silva C, Cruz A, Lemos Miguel MA, Farah A	Food Funct	10.1039/c9fo02589h	2020	*
Pathogenicity	Probiotics exert reciprocal effects on autophagy and interleukin-1beta expression in Salmonella-infected intestinal epithelial cells via autophagy-related 16L1 protein.	Lai WT, Huang FC	Benef Microbes	10.3920/BM2019.0046	2019	*
Biotechnology	Matrix-wise evaluation of in vivo and in vitro efficiencies of L. rhamnosus GG-fortified beverages.	Sireswar S, Dey G	Food Res Int	10.1016/j.foodres.2018.10.077	2018	*
Phylogeny	Evaluation of probiotic potential and anti-hyperglycemic properties of a novel Lactobacillus strain isolated from water kefir grains.	Koh WY, Utra U, Ahmad R, Rather IA, Park YH	Food Sci Biotechnol	10.1007/s10068-018-0360-y	2018	*
Cultivation	Lactobacillus rhamnosus LRB mediated inhibition of oral streptococci.	Biswas S, Turner L, Biswas I	Mol Oral Microbiol	10.1111/omi.12242	2018	*
Pathogenicity	Flow Cytometry: Evolution of Microbiological Methods for Probiotics Enumeration.	Pane M, Allesina S, Amoruso A, Nicola S, Deidda F, Mogna L	J Clin Gastroenterol	10.1097/MCG.0000000000001057	2018	*
Phylogeny	Antibacterial effects of bacteriocins isolated from Lactobacillus rhamnosus (ATCC 53103) in a rabbit model of knee implant infection.	Zhou B, Zhang D	Exp Ther Med	10.3892/etm.2018.5790	2018	*
Pathogenicity	Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation.	Koyama S, Fujita H, Shimosato T, Kamijo A, Ishiyama Y, Yamamoto E, Ishii Y, Hattori Y, Hagihara M, Yamazaki E, Tomita N, Nakajima H	Probiotics Antimicrob Proteins	10.1007/s12602-018-9399-6	2019	*
Pathogenicity	Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.	Kane AF, Bhatia AD, Denning PW, Shane AL, Patel RM	J Pediatr	10.1016/j.jpeds.2017.11.055	2018	*
Pathogenicity	Effect of phenolic compounds on the growth of selected probiotic and pathogenic bacteria.	Pacheco-Ordaz R, Wall-Medrano A, Goni MG, Ramos-Clamont-Montfort G, Ayala-Zavala JF, Gonzalez-Aguilar GA	Lett Appl Microbiol	10.1111/lam.12814	2018	*
Pathogenicity	Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol.	Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean MJ, O'Connell KJ, Mahajan P, Chun TH, Bhatt SR, Roskind CG, Powell EC, Rogers AJ, Vance C, Sapien RE, Gao F, Freedman SB	BMJ Open	10.1136/bmjopen-2017-018115	2017	*
Metabolism	A comparative study of procedures for binding of aflatoxin M1 to Lactobacillus rhamnosus GG.	Assaf JC, Atoui A, Khoury AE, Chokr A, Louka N	Braz J Microbiol	10.1016/j.bjm.2017.05.003	2017	*
Metabolism	In vitro fermentation of oat beta-glucan and hydrolysates by fecal microbiota and selected probiotic strains.	Dong JL, Yu X, Dong LE, Shen RL	J Sci Food Agric	10.1002/jsfa.8292	2017	*
Stress	Live and heat-killed Lactobacillus spp. interfere with Streptococcus mutans and Streptococcus oralis during biofilm development on titanium surface.	Ciandrini E, Campana R, Baffone W	Arch Oral Biol	10.1016/j.archoralbio.2017.02.004	2017	*
Pathogenicity	Protective Role of Postbiotic Mediators Secreted by Lactobacillus rhamnosus GG Versus Lipopolysaccharide-induced Damage in Human Colonic Smooth Muscle Cells.	Cicenia A, Santangelo F, Gambardella L, Pallotta L, Iebba V, Scirocco A, Marignani M, Tellan G, Carabotti M, Corazziari ES, Schippa S, Severi C	J Clin Gastroenterol	10.1097/MCG.0000000000000681	2016	*
Metabolism	Human milk and mucosal lacto- and galacto-N-biose synthesis by transgalactosylation and their prebiotic potential in Lactobacillus species.	Bidart GN, Rodriguez-Diaz J, Palomino-Schatzlein M, Monedero V, Yebra MJ	Appl Microbiol Biotechnol	10.1007/s00253-016-7882-0	2016	*
Metabolism	Characterization of biosurfactants produced by Lactobacillus spp. and their activity against oral streptococci biofilm.	Ciandrini E, Campana R, Casettari L, Perinelli DR, Fagioli L, Manti A, Palmieri GF, Papa S, Baffone W	Appl Microbiol Biotechnol	10.1007/s00253-016-7531-7	2016	*
Metabolism	Immunological mechanisms involved in probiotic-mediated protection against Citrobacter rodentium-induced colitis.	Jiang Y, Yang G, Meng F, Yang W, Hu J, Ye L, Shi C, Wang C	Benef Microbes	10.3920/BM2015.0119	2016	*
Metabolism	Supplementation of xylitol-containing chewing gum with probiotics: a double blind, randomised pilot study focusing on saliva flow and saliva properties.	Gueimonde L, Vesterlund S, Garcia-Pola MJ, Gueimonde M, Soderling E, Salminen S	Food Funct	10.1039/c5fo01497b	2016	*
Pathogenicity	Transcriptomic Profile of Whole Blood Cells from Elderly Subjects Fed Probiotic Bacteria Lactobacillus rhamnosus GG ATCC 53103 (LGG) in a Phase I Open Label Study.	Solano-Aguilar G, Molokin A, Botelho C, Fiorino AM, Vinyard B, Li R, Chen C, Urban J Jr, Dawson H, Andreyeva I, Haverkamp M, Hibberd PL	PLoS One	10.1371/journal.pone.0147426	2016	*
Metabolism	An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface.	Alvarez B, Krogh-Andersen K, Tellgren-Roth C, Martinez N, Gunaydin G, Lin Y, Martin MC, Alvarez MA, Hammarstrom L, Marcotte H	Appl Environ Microbiol	10.1128/AEM.00945-15	2015	*
Genetics	Correlation of Lactobacillus rhamnosus Genotypes and Carbohydrate Utilization Signatures Determined by Phenotype Profiling.	Ceapa C, Lambert J, van Limpt K, Wels M, Smokvina T, Knol J, Kleerebezem M	Appl Environ Microbiol	10.1128/AEM.00851-15	2015	*
Phylogeny	Functional dynamics of the gut microbiome in elderly people during probiotic consumption.	Eloe-Fadrosh EA, Brady A, Crabtree J, Drabek EF, Ma B, Mahurkar A, Ravel J, Haverkamp M, Fiorino AM, Botelho C, Andreyeva I, Hibberd PL, Fraser CM	mBio	10.1128/mBio.00231-15	2015	*
Pathogenicity	A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial.	Partty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E	Pediatr Res	10.1038/pr.2015.51	2015	*
Pathogenicity	No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.	Hibberd PL, Kleimola L, Fiorino AM, Botelho C, Haverkamp M, Andreyeva I, Poutsiaka D, Fraser C, Solano-Aguilar G, Snydman DR	PLoS One	10.1371/journal.pone.0113456	2014	*
Metabolism	Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation.	Tomaro-Duchesneau C, Jones ML, Shah D, Jain P, Saha S, Prakash S	Biomed Res Int	10.1155/2014/380316	2014	*
Pathogenicity	Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction.	Sadowska-Krawczenko I, Paprzycka M, Korbal P, Wiatrzyk A, Krysztopa-Grzybowska K, Polak M, Czajka U, Lutynska A	Benef Microbes	10.3920/BM2013.0074	2014	*
Metabolism	Comparative genome analysis of Lactobacillus rhamnosus clinical isolates from initial stages of dental pulp infection: identification of a new exopolysaccharide cluster.	Nadkarni MA, Chen Z, Wilkins MR, Hunter N	PLoS One	10.1371/journal.pone.0090643	2014	*
Pathogenicity	Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.	Sindhu KN, Sowmyanarayanan TV, Paul A, Babji S, Ajjampur SS, Priyadarshini S, Sarkar R, Balasubramanian KA, Wanke CA, Ward HD, Kang G	Clin Infect Dis	10.1093/cid/ciu065	2014	*
Pathogenicity	Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial.	Luoto R, Ruuskanen O, Waris M, Kalliomaki M, Salminen S, Isolauri E	J Allergy Clin Immunol	10.1016/j.jaci.2013.08.020	2013	*
Pathogenicity	Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage.	Ammoscato F, Scirocco A, Altomare A, Matarrese P, Petitta C, Ascione B, Caronna R, Guarino M, Marignani M, Cicala M, Chirletti P, Malorni W, Severi C	Neurogastroenterol Motil	10.1111/nmo.12232	2013	*
Pathogenicity	The development of probiotic treatment in obesity: a review.	Mekkes MC, Weenen TC, Brummer RJ, Claassen E	Benef Microbes	10.3920/BM2012.0069	2014	*
Genetics	Evaluation of strain-specific primers for identification of Lactobacillus rhamnosus GG.	Endo A, Aakko J, Salminen S	FEMS Microbiol Lett	10.1111/1574-6968.12015	2012	*
Enzymology	Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.	Piano MD, Carmagnola S, Ballare M, Balzarini M, Montino F, Pagliarulo M, Anderloni A, Orsello M, Tari R, Sforza F, Mogna L, Mogna G	J Clin Gastroenterol	10.1097/MCG.0b013e3182672796	2012	*
Pathogenicity	Effect of LGG yoghurt on Streptococcus mutans and Lactobacillus spp. salivary counts in children.	Glavina D, Gorseta K, Skrinjaric I, Vranic DN, Mehulic K, Kozul K	Coll Antropol		2012	*
Metabolism	Characterization of a Panela cheese with added probiotics and fava bean starch.	Escobar MC, Van Tassell ML, Martinez-Bustos F, Singh M, Castano-Tostado E, Amaya-Llano SL, Miller MJ	J Dairy Sci	10.3168/jds.2011-4655	2012	*
Genetics	Whole-genome shotgun sequencing of Lactobacillus rhamnosus MTCC 5462, a strain with probiotic potential.	Prajapati JB, Khedkar CD, Chitra J, Suja S, Mishra V, Sreeja V, Patel RK, Ahir VB, Bhatt VD, Sajnani MR, Jakhesara SJ, Koringa PG, Joshi CG	J Bacteriol	10.1128/JB.06644-11	2012	*
Biotechnology	Characterization of certain bacterial strains for potential use as starter or probiotic cultures in dairy products.	Monteagudo-Mera A, Caro I, Rodriguez-Aparicio LB, Rua J, Ferrero MA, Garcia-Armesto MR	J Food Prot	10.4315/0362-028X.JFP-10-392	2011	*
Pathogenicity	In vitro selection of antibiotic resistance in the probiotic strain Lactobacillus rhamnosus GG ATCC 53103.	Drago L, Rodighiero V, Mattina R, Toscano M, DE Vecchi E	J Chemother	10.1179/joc.2011.23.4.211	2011	*
Pathogenicity	Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis.	Nermes M, Kantele JM, Atosuo TJ, Salminen S, Isolauri E	Clin Exp Allergy	10.1111/j.1365-2222.2010.03657.x	2010	*
Enzymology	Manufacturing process influences properties of probiotic bacteria.	Grzeskowiak L, Isolauri E, Salminen S, Gueimonde M	Br J Nutr	10.1017/S0007114510004496	2010	*
Pathogenicity	Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial.	Ilmonen J, Isolauri E, Poussa T, Laitinen K	Clin Nutr	10.1016/j.clnu.2010.09.009	2011	*
Cultivation	Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions.	Marianelli C, Cifani N, Pasquali P	Res Microbiol	10.1016/j.resmic.2010.06.007	2010	*
Metabolism	Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.	Linsalata M, Cavallini A, Messa C, Orlando A, Refolo MG, Russo F	Curr Pharm Des	10.2174/138161210790883598	2010	*
Pathogenicity	The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years.	Luoto R, Kalliomaki M, Laitinen K, Isolauri E	Int J Obes (Lond)	10.1038/ijo.2010.50	2010	*
Genetics	Complete genome sequence of the probiotic Lactobacillus rhamnosus ATCC 53103.	Morita H, Toh H, Oshima K, Murakami M, Taylor TD, Igimi S, Hattori M	J Bacteriol	10.1128/JB.01287-09	2009	*
Enzymology	Comparison of inactivation pathways of thermal or high pressure inactivated Lactobacillus rhamnosus ATCC 53103 by flow cytometry analysis.	Ananta E, Knorr D	Food Microbiol	10.1016/j.fm.2009.01.008	2009	*
Phylogeny	Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group.	Coudeyras S, Marchandin H, Fajon C, Forestier C	Appl Environ Microbiol	10.1128/AEM.02286-07	2008	*
Metabolism	Impact of environmental and genetic factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus GG.	Lebeer S, Verhoeven TL, Perea Velez M, Vanderleyden J, De Keersmaecker SC	Appl Environ Microbiol	10.1128/AEM.01393-07	2007	*
Metabolism	Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG.	Perea Velez M, Verhoeven TL, Draing C, Von Aulock S, Pfitzenmaier M, Geyer A, Lambrichts I, Grangette C, Pot B, Vanderleyden J, De Keersmaecker SC	Appl Environ Microbiol	10.1128/AEM.02083-06	2007	*
Metabolism	Growth of probiotic bacteria and bifidobacteria in a soy yogurt formulation.	Farnworth ER, Mainville I, Desjardins MP, Gardner N, Fliss I, Champagne C	Int J Food Microbiol	10.1016/j.ijfoodmicro.2006.12.015	2007	*
Pathogenicity	Intestinal colonisation, microbiota and future probiotics?	Salminen S, Benno Y, de Vos W	Asia Pac J Clin Nutr		2006	*
Phylogeny	Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota.	Rinne M, Kalliomaki M, Salminen S, Isolauri E	J Pediatr Gastroenterol Nutr	10.1097/01.mpg.0000228106.91240.5b	2006	*
Phylogeny	Probiotic lactobacilli and bacteraemia in Stockholm.	Sullivan A, Nord CE	Scand J Infect Dis	10.1080/00365540500449826	2006	*
Pathogenicity	Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.	Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E	Lancet	10.1016/S0140-6736(03)13490-3	2003	*
Pathogenicity	Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors.	Ahola AJ, Yli-Knuuttila H, Suomalainen T, Poussa T, Ahlstrom A, Meurman JH, Korpela R	Arch Oral Biol	10.1016/s0003-9969(02)00112-7	2002	*
Genetics	Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103).	Landersjo C, Yang Z, Huttunen E, Widmalm G	Biomacromolecules	10.1021/bm020040q	2002	*
Pathogenicity	No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.	Helin T, Haahtela S, Haahtela T	Allergy	10.1034/j.1398-9995.2002.1s3299.x	2002	*
Metabolism	Surface binding of aflatoxin B(1) by lactic acid bacteria.	Haskard CA, El-Nezami HS, Kankaanpaa PE, Salminen S, Ahokas JT	Appl Environ Microbiol	10.1128/AEM.67.7.3086-3091.2001	2001	*
Pathogenicity	Characterization of the properties of human- and dairy-derived probiotics for prevention of infectious diseases in fish.	Nikoskelainen S, Salminen S, Bylund G, Ouwehand AC	Appl Environ Microbiol	10.1128/AEM.67.6.2430-2435.2001	2001	*
Pathogenicity	Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein.	Pessi T, Isolauri E, Sutas Y, Kankaanranta H, Moilanen E, Hurme M	Int Immunopharmacol	10.1016/s1567-5769(00)00018-7	2001	*
Pathogenicity	Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG.	Pessi T, Sutas Y, Hurme M, Isolauri E	Clin Exp Allergy	10.1046/j.1365-2222.2000.00948.x	2000	*
Phylogeny	Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes.	Tynkkynen S, Singh KV, Varmanen P	Int J Food Microbiol	10.1016/s0168-1605(98)00051-8	1998	*
Pathogenicity	Recovery of Lactobacillus rhamnosus GG from human colonic biopsies.	Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A	Lett Appl Microbiol	10.1046/j.1472-765x.1997.00140.x	1997	*
Metabolism	Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro.	Meurman JH, Antila H, Korhonen A, Salminen S	Eur J Oral Sci	10.1111/j.1600-0722.1995.tb00169.x	1995	*
Metabolism	Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens.	Chen PW, Jheng TT, Shyu CL, Mao FC	J Dairy Sci	10.3168/jds.2012-6112	2013	*
Pathogenicity	Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro.	Korpela R, Moilanen E, Saxelin M, Vapaatalo H	Int J Food Microbiol	10.1016/s0168-1605(97)00049-4	1997	*
Pathogenicity	In vitro characterization of lactic acid bacterial strains isolated from fermented foods with anti-inflammatory and dipeptidyl peptidase-IV inhibition potential.	Bhatia R, Singh S, Maurya R, Bhadada SK, Bishnoi M, Chopra K, Joshi SR, Kondepudi KK	Braz J Microbiol	10.1007/s42770-022-00872-5	2022	*
Phylogeny	Anti-Biofilm Activity of Cell Free Supernatants of Selected Lactic Acid Bacteria against Listeria monocytogenes Isolated from Avocado and Cucumber Fruits, and from an Avocado Processing Plant.	Masebe RD, Thantsha MS	Foods	10.3390/foods11182872	2022	*
	Improvement of probiotic viability through the design of novel biomaterials using coffee pulp wastes and Lactobacillus rhamnosus.	Rosales Delgado S, Alzate Arbelaez AF, Zapata Acosta K, Cortes FB, Rojano BA	Food Sci Technol Int	10.1177/10820132221100683	2022	*
	Microencapsulation of Lactobacillus casei and Lactobacillus rhamnosus in pectin and pectin-inulin microgel particles: Effect on bacterial survival under storage conditions.	Tarifa MC, Piqueras CM, Genovese DB, Brugnoni LI	Int J Biol Macromol	10.1016/j.ijbiomac.2021.03.038	2021	*
	Biodiversity of meatborne Listeria spp. in Himachal Pradesh and their interaction with indigenous probiotics.	Sharma A, Kanwar SS, Thakur SD	J Food Sci Technol	10.1007/s13197-020-04854-z	2020	*
	Probiotic Lactobacillus rhamnosus GG Promotes Mouse Gut Microbiota Diversity and T Cell Differentiation.	Shi CW, Cheng MY, Yang X, Lu YY, Yin HD, Zeng Y, Wang RY, Jiang YL, Yang WT, Wang JZ, Zhao DD, Huang HB, Ye LP, Cao X, Yang GL, Wang CF	Front Microbiol	10.3389/fmicb.2020.607735	2020	*
	A Validated Real-Time PCR Method for the Specific Identification of Probiotic Strain Lactobacillus rhamnosus GG (ATCC 53103).	Shehata HR, Newmaster SG	J AOAC Int	10.1093/jaoacint/qsaa063	2020	*
	Development and Comparative Evaluation of a Novel Fermented Juice Mixture with Probiotic Strains of Lactic Acid Bacteria and Bifidobacteria.	Guney D, Gungormusler M	Probiotics Antimicrob Proteins	10.1007/s12602-020-09710-2	2020	*
	Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis.	Sabbatini S, Monari C, Ballet N, Decherf AC, Bozza S, Camilloni B, Perito S, Vecchiarelli A	Microorganisms	10.3390/microorganisms8091294	2020	*
	First Evidence of Acyl-Hydrolase/Lipase Activity From Human Probiotic Bacteria: Lactobacillus rhamnosus GG and Bifidobacterium longum NCC 2705.	Manasian P, Bustos AS, Palsson B, Hakansson A, Penarrieta JM, Nilsson L, Linares-Pasten JA	Front Microbiol	10.3389/fmicb.2020.01534	2020	*
	New insights in enumeration methodologies of probiotic cells in finished products.	Foglia C, Allesina S, Amoruso A, De Prisco A, Pane M	J Microbiol Methods	10.1016/j.mimet.2020.105993	2020	*
	A Pilot Randomized Control Trial With the Probiotic Strain Lactobacillus rhamnosus GG (LGG) in ADHD: Children and Adolescents Report Better Health-Related Quality of Life.	Kumperscak HG, Gricar A, Ulen I, Micetic-Turk D	Front Psychiatry	10.3389/fpsyt.2020.00181	2020	*
	Oral administration of Lactobacillus rhamnosus GG to newborn piglets augments gut barrier function in pre-weaning piglets.	Wang Y, Gong L, Wu YP, Cui ZW, Wang YQ, Huang Y, Zhang XP, Li WF	J Zhejiang Univ Sci B	10.1631/jzus.B1800022	2019	*
	In silico Prediction, in vitro Antibacterial Spectrum, and Physicochemical Properties of a Putative Bacteriocin Produced by Lactobacillus rhamnosus Strain L156.4.	Oliveira LC, Silveira AMM, Monteiro AS, Dos Santos VL, Nicoli JR, Azevedo VAC, Soares SC, Dias-Souza MV, Nardi RMD	Front Microbiol	10.3389/fmicb.2017.00876	2017	*
	An improved pH-responsive carrier based on EDTA-Ca-alginate for oral delivery of Lactobacillus rhamnosus ATCC 53103.	Zheng H, Gao M, Ren Y, Lou R, Xie H, Yu W, Liu X, Ma X	Carbohydr Polym	10.1016/j.carbpol.2016.08.096	2016	*
	Capability of exopolysaccharide-producing Lactobacillus paraplantarum BGCG11 and its non-producing isogenic strain NB1, to counteract the effect of enteropathogens upon the epithelial cell line HT29-MTX.	Zivkovic M, Hidalgo-Cantabrana C, Kojic M, Gueimonde M, Golic N, Ruas-Madiedo P	Food Res Int	10.1016/j.foodres.2015.05.012	2015	*
	Genome instability in Lactobacillus rhamnosus GG.	Sybesma W, Molenaar D, van IJcken W, Venema K, Kort R	Appl Environ Microbiol	10.1128/AEM.03566-12	2013	*
	Dietary addition of Lactobacillus rhamnosus GG impairs the health of Escherichia coli F4-challenged piglets.	Trevisi P, Casini L, Coloretti F, Mazzoni M, Merialdi G, Bosi P	Animal	10.1017/S1751731111000462	2011	*
	Removal of cholera toxin from aqueous solution by probiotic bacteria.	Heikkila JE, Nybom SM, Salminen SJ, Meriluoto JA	Pharmaceuticals (Basel)	10.3390/ph5060665	2012	*
	Stability of lactobacilli encapsulated in various microbial polymers.	Jimenez-Pranteda ML, Poncelet D, Nader-Macias ME, Arcos A, Aguilera M, Monteoliva-Sanchez M, Ramos-Cormenzana A	J Biosci Bioeng	10.1016/j.jbiosc.2011.10.010	2011	*
	Immune enhancement in rainbow trout (Oncorhynchus mykiss) by potential probiotic bacteria (Lactobacillus rhamnosus).	Nikoskelainen S, Ouwehand AC, Bylund G, Salminen S, Lilius EM	Fish Shellfish Immunol	10.1016/s1050-4648(03)00023-8	2003	*
	In vitro assessment of probiotic attributes for strains contained in commercial formulations.	Mazzantini D, Calvigioni M, Celandroni F, Lupetti A, Ghelardi E	Sci Rep	10.1038/s41598-022-25688-z	2022	*
	Rationale, design, and methods: A randomized placebo-controlled trial of an immunomodulatory probiotic intervention for Veterans with PTSD.	Brenner LA, Stearns-Yoder KA, Stamper CE, Hoisington AJ, Brostow DP, Hoffmire CA, Forster JE, Donovan ML, Ryan AT, Postolache TT, Lowry CA	Contemp Clin Trials Commun	10.1016/j.conctc.2022.100960	2022	*

References

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#52036 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 34291

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#66794

Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 )

#68371

Automatically annotated from API 50CH acid .

#68381

Automatically annotated from API rID32STR .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#102489

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID8915.1 )

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Lactobacillus rhamnosus in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Lacticaseibacillus rhamnosus GG ATCC 53103

Lacticaseibacillus rhamnosus GG GG (ATCC 53103)

Change proposal

Change proposal